The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis

March 2, 2021 updated by: MOHAMED SAEED M. ALI

The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis :A Randomized Controlled Trial

the efficacy of commercially available oregano essential oil mouthwash in the reduction of oral halitosis was compared to chlorhexidine and distilled water and the results showed significant reduction of organoleptic tongue and floss scores and BANA test scores compared to placebo

Study Overview

Status

Completed

Conditions

Detailed Description

the results showed that oregawash showed a comparable effect to chx in reducing oral halitosis

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rasafa
      • Baghdad, Rasafa, Iraq, 00964
        • Univeristy of Baghdad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 21 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Organoleptic score was >2 at baseline.
  2. Participants between 18-23 years of age.
  3. The subjects had no systemic disease and were not taking antibiotics or receiving other antimicrobial therapy.
  4. The subjects did not receive the same time treatment for their halitosis.

Exclusion Criteria:

  1. Smokers, alcoholics and drug addicts.
  2. Patients with periodontitis or pocket depth >6 mm.
  3. Patients taking drugs which induced xerostomia.
  4. Subjects consuming spicy food: garlic or onions two days before examination.
  5. Patients with orthodontic appliances or removable dentures.
  6. pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: oregano
oregawash mouthwash was used twice times daily for 7 days
mouthwash containing oregano essential oil
Placebo Comparator: placebo
distilled water was used twice times daily for 7 days
distilled water
Other Names:
  • distilled water
Active Comparator: chlorhexidine
Corsodyl with 0.2%CHX mouthwash was used twice times daily for 7 days
0.2% chlorhexidine mouthwash
Other Names:
  • chlorhexdine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
organoleptic tongue and floss scores
Time Frame: 9 month
organoleptic measuements
9 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BANA test
Time Frame: 9 month
chair side BANA test
9 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: mohamed s albana, director, Univeristy of Baghdad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2020

Primary Completion (Actual)

November 15, 2020

Study Completion (Actual)

November 17, 2020

Study Registration Dates

First Submitted

February 27, 2021

First Submitted That Met QC Criteria

February 27, 2021

First Posted (Actual)

March 3, 2021

Study Record Updates

Last Update Posted (Actual)

March 4, 2021

Last Update Submitted That Met QC Criteria

March 2, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Halitosis

3
Subscribe